GLO Healthcare  an expanding healthcare platform created by CapVest Partners LLP  has , in partnership with management, completed the acquisition of Calyx, a leading provider of mission-critical software and technology services for the high-growth clinical research market.

The terms of the transaction are not disclosed.

Based in the US and UK, Calyx employs more than 1,900 professionals in seven offices in six countries, providing 24/7 services to most of the world's leading biopharmaceutical companies. The company is structured around three areas of specialization encompassing medical imaging, interactive response technology and enterprise technologies (clinical trial management system, regulatory information management software and electronic data capture software) .

Calyx's market-leading service, scientific knowledge, expertise and technology offering accelerate the delivery of life-saving treatments to millions of patients around the world by improving clinical outcomes. Its clients include the world's top 20 pharmaceutical companies, and to date Calyx has supported more than 60,000 trials in all clinical phases. Recently, Calyx has made significant investments to develop its next generation of cloud products, significantly strengthening its value proposition and service levels.

Under CapVest's leadership, GLO Healthcare specializes in the development and delivery of superior diagnostic tests and innovative therapies for all major cancers and other life-threatening diseases.

CapVest is an international investment company managing EUR 7.5 billion in assets. As an active and patient investor, CapVest has a strong track record of working closely with management to transform the size, scale and outlook of its portfolio companies. CapVest has a proven track record of building high-performing, market-leading businesses through significant investments in talent, technology, innovation, capability, and organic and acquisition-driven growth.

Kate Briant, Partner at CapVest: "The acquisition of Calyx represents a very attractive opportunity to combine CapVest's extensive experience and financial strength with Calyx's unique technology, expertise and service offering. We have promising plans to accelerate the growth and development of the company in order to firmly position Calyx as a global leader in e-clinical services.We look forward to starting our collaboration with Calyx management and teams in 2023. We we will build on and support our past successes to optimize the depth, scope and quality of client services, with a view to delivering life-saving treatments to patients."

End

The text of the press release resulting from a translation should in no way be considered official. The only authentic version of the press release is that of the press release in its original language. The translation will always have to be compared with the source text, which will set a precedent.

contacts
For more information, please contact:

On behalf of CapVest and GLO Healthcare:
Ben Valdimarsson
ReputationInc
bvaldimarsson@reputation-inc.com
Mobile: +44 (0) 7889805930

On behalf of Calyx:
Christine Tobin
Calyx
christine.tobin@calyx.ai
Mobile: +1 412 628-8598

 

Source:businesswire.com

Report Abuse